August 15, 2019
Ultragenyx Enters Partnership with GeneTx to Develop Angelman Syndrome ASO
Read More
August 13, 2019
Jazz Pharmaceuticals Acquires Neurological Drug Developer
Read More
August 8, 2019
Bayer Bets on Cell Therapy with Buyout of BlueRock Therapeutics
Read More
August 7, 2019
Selecta Partners with AskBio to Develop AAV Gene Therapies That Can Be Re-Dosed
Read More
July 26, 2019
Zambon Acquires Breath Therapeutics for Its Late-Stage Lung Disease Drug
Read More
July 25, 2019
Iveric Bio Expands Gene Therapy Portfolio for Rare Retinal Diseases
Read More
July 24, 2019
Exscientia and Rallybio Form Joint Venture for Rare Disease Drug Discovery
Read More
July 15, 2019
Recordati Acquires Rights to Novartis’ Rare Endocrine Disease Drugs
Read More
July 2, 2019
PTC Therapeutics and Odylia Partner to Gene Therapies for Retinal Diseases
Read More
June 26, 2019
Oxford Biomedica and Santen Collaborate on Gene Therapy Vectors for Retinal Disease
Read More
June 19, 2019
Ultragenyx and Arcturus Expand Collaboration to Develop Nucleic Acid Therapies
Read More
June 19, 2019
Retrophin Enters Agreement with NCATS and Patient Group to Identify Potential Therapies for Alagille Syndrome
Read More
Load More
X